Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.

Autor: Mulyukov Z; Novartis Pharmaceuticals AG, Basel, Switzerland., Keane PA; NIHR Moorfields Biomedical Research Centre, London, United Kingdom.; UCL Institute of Ophthalmology, London, United Kingdom., Sahni J; Novartis Pharmaceuticals AG, Basel, Switzerland., Liakopoulos S; Cologne Image Reading Center and Laboratory, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Department of Ophthalmology, Goethe University, Frankfurt, Germany., Hatz K; Vista Augenklinik Binningen, Binningen, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland., Wei Ting DS; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore., Gallego-Pinazo R; Oftalvist Clinic, Valencia, Spain., Aslam T; School of Pharmacy and Optometry, University of Manchester, Manchester Royal Eye Hospital, Manchester, United Kingdom., Gemmy Cheung CM; Duke-NUS Academic Clinical Programme, University of Singapore, Singapore, Republic of Singapore.; Singapore National Eye Centre, Singapore, Republic of Singapore., De Salvo G; Ophthalmology Department, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Semoun O; Centre Hospitalier Intercommunal de Créteil, Créteil, France.; Institut d'Ophtalmologie du Panthéon, Paris, France., Somfai GM; Stadtspital Zürich, Department of Ophthalmology, Zürich, Switzerland.; Spross Research Institute, Zürich, Switzerland.; Department of Ophthalmology, Semmelweis University, Budapest, Hungary., Stahl A; Department of Ophthalmology, University Hospital Greifswald, Greifswald, Germany., Lujan BJ; OHSU Casey Eye Institute, Portland, Oregon., Lorand D; Novartis Pharmaceuticals AG, Basel, Switzerland.

Publikováno v: Ophthalmology science [Ophthalmol Sci] 2024 Jun 17; Vol. 4 (6), pp. 100565. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).

Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.

Autor: Schmidt-Erfurth U; Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria. ursula.schmidt-erfurth@meduniwien.ac.at., Mulyukov Z; Novartis Pharma AG, Basel, Switzerland., Gerendas BS; Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria., Reiter GS; Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria., Lorand D; Novartis Pharma AG, Basel, Switzerland., Weissgerber G; Novartis Pharma AG, Basel, Switzerland., Bogunović H; Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Publikováno v: Eye (London, England) [Eye (Lond)] 2023 Apr; Vol. 37 (6), pp. 1160-1169. Date of Electronic Publication: 2022 May 06.

Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study.

Autor: Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany., Abreu-Gonzalez R; Department of Ophthalmology, University Hospital of La Candelaria, Santa Cruz de Tenerife, Spain., Bandello F; Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, University Vita Salute Hospital San Raffaele, Milano, Italy., Duval R; Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada., O'Toole L; Department of Ophthalmology, Bon Secours Hospital Dublin, Dublin, Ireland., Pauleikhoff D; Department of Ophthalmology, St. Franzikus-Hospital, Münster, Germany., Staurenghi G; Dipartimento di Scienze Cliniche Luigi Sacco, Eye Clinic, University of Milan, Milan, Italy., Wolf A; Department of Ophthalmology, University of Ulm, Ulm, Germany., Lorand D; Novartis Pharma AG, Basel, Switzerland., Clemens A; Novartis Pharma AG, Basel, Switzerland.; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany., Gmeiner B; Novartis Pharma GmbH, Nuremberg, Germany benjamin.gmeiner@novartis.com.

Publikováno v: The British journal of ophthalmology [Br J Ophthalmol] 2023 Jan; Vol. 107 (1), pp. 96-101. Date of Electronic Publication: 2021 Aug 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Indian Problem in Guatemala and Bolivia

Autor: Schweng, Lorand D.

Publikováno v: The World Today, 1961 Sep 01. 17(9), 401-410.

Externí odkaz: https://www.jstor.org/stable/40393266